Mohamed Ashraf Elsawaf, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 301 Bingham Ave, Suite 1b, Ocean, NJ 07712 Phone: 732-775-9075 Fax: 732-775-1212 |
Dr. Rana Y Ali, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 301 Bingham Avenue, Suite B, Ocean, NJ 07712 Phone: 732-575-1100 Fax: 732-575-1107 |
Matthew Frank, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 301 Bingham Ave, Ocean, NJ 07712 Phone: 732-775-9075 Fax: 732-775-1212 |
Dr. James Patrick Cosentino, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 301 Bingham Avenue, Suite B, Ocean, NJ 07712 Phone: 732-575-1100 Fax: 732-575-1107 |
News Archive
A proof-of-concept study carried out at UCL Institute of Ophthalmology with funding from Fight for Sight has highlighted the potential of a targeted antisense oligonucleotide therapy to treat Fuchs endothelial corneal dystrophy patients with a mutation in the TCF4 gene.
Published today in Nature, the findings detail a new gene locus that can explain why, in communities where everyone is constantly exposed to malaria, some children develop severe malaria and others don't. Now, researchers can be sure that this particular stretch of our DNA plays a crucial role in the progression of the disease.
Lighthouse Instruments, LLC, a world leader in laser test and measurement systems for pharmaceutical process monitoring, today announced a strategic business partnership with Robert Bosch, GmbH to develop and distribute a new machine series for container closure integrity (CCI) testing using Lighthouse's laser headspace analysis (HSA) technology.
UK men and women say reducing their risk of cancer is last on a list of reasons to exercise, according to a national survey by Cancer Research UK and Cannons.
A tiny capsule that can carry out a chemical analysis of the contents of one's stomach could identify the presence of so-called "occult" blood at very low levels. The data is automatically broadcast to an external monitoring device for detection of early stage stomach cancer by one's physician. Details of the invention and initial trials are described in a forthcoming issue of the International Journal of Biomedical Engineering and Technology.
› Verified 2 days ago